The latest update is out from Hydreight Technologies Inc ( (TSE:NURS) ).
Hydreight Technologies Inc. has expanded its VSDHOne platform by introducing NAD+ therapy in new delivery formats, including patch, injection, and nasal spray. This strategic move positions the company to capitalize on the growing anti-aging and longevity market, aligning with consumer demand for advanced wellness solutions and strengthening its position in science-backed longevity treatments.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. is a rapidly growing mobile clinical network and medical platform that offers flexible at-home medical services across the United States. The company focuses on providing innovative and accessible wellness solutions through its national telehealth network.
YTD Price Performance: -4.55%
Average Trading Volume: 127,860
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$42.78M
For detailed information about NURS stock, go to TipRanks’ Stock Analysis page.